Insmed

159.19
开盘价
161.51
市值
35.01B+
最高价
164.53
最低价
157.52
收盘价
162.43
成交量
1.81M+
市盈率
-25.30
股息率
0.00%

Insmed简介

Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。公司网站:http://www.insmed.com公司地址:700 US Highway 202/206 Bridgewater New Jersey 08807

如何购买 Insmed (INSM)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 INSM

购买 INSM

通过 RockFlow App 或网页端搜索 INSM,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.